Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

The deal is the second Chinese oncology pact in as many weeks for AbbVie, which also committed $175 million for a ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

Ghanaian-born researcher David U. Mualen, a PhD candidate in Biomedical Engineering in the United States, is gaining international recognition for research that is reshaping how modern medicines are ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Scientists have developed a new treatment strategy that could one day save the lives of children affected by aggressive brain ...

A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

Two formative experiences shaped Craig Crews’ path into drug development. First, when he was still a child, his grandmother died from cancer at just 52 years old. “At the time, there weren’t very many ...

Advances in cancer research have led to an increasing number and variety of cancer therapies in the development pipeline, but there are concerns that traditional processes for drug development, ...

Celcuity, the Plymouth-based clinical-stage biotechnology company, has been the best-performing Minnesota stock of the summer and has outperformed all the S&P 500 stocks, including the tech giants ...